MET Exon 14 Skipping Mutations in Lung Cancer: Clinical–Pathological Characteristics and Immune Microenvironment.
Simple Summary: Lung cancer is a leading cause of cancer-related deaths, but new treatments targeting specific gene changes have improved outcomes for many patients. One such change, called MET exon 14 skipping, occurs in a small group of patients and is linked to more aggressive tumors. While targe...
| Publicado en: | Current Oncology Vol. 32; no. 7; pp. 403 - 418 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jul2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |